Seeking Health Hydroxo-Adeno B12, 2,000 mcg, 60 Lozenges
UPC: 810007520490
Seeking Health's Hydroxo-Adeno B12 is a methyl-free vitamin B12 lozenge designed for individuals sensitive to methylated nutrients, such as methylcobalamin. It provides 2,000 mcg of B12 from two non-methylated forms: hydroxocobalamin and adenosylcobalamin. According to the manufacturer, hydroxocobalamin may support detoxification processes, while adenosylcobalamin is involved in mitochondrial energy production.
This product is formulated to avoid the side effects some experience with methyl donors, offering a slower delivery of B12 through enzymatic conversion in the body. The lozenge form uses xylitol as a sweetener and comes in a natural cherry flavor. Suggested use involves starting with half a lozenge and adjusting as needed, with guidance to avoid taking it close to bedtime. It is suitable for a wide range of users, including those who are vegan, pregnant, or have undergone bariatric surgery.
At a glance
Supplement Facts
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Vitamin B12 (as hydroxocobalamin and adenosylcobalamin) | 2,000 mcg | 83,333% |
| † Daily Value not established | ||
Other Ingredients
Xylitol, ascorbyl palmitate, natural cherry flavor, malic acid, and silica.
Does not contain dairy, eggs, fish, shellfish, tree nuts, peanuts, wheat, soy, sesame, gluten, or GMO.
Label Information
Directions, warnings, and other information directly from the product label.
Suggested Use
Initial use for the first week, take 1/2 a lozenge by mouth, let dissolve slowly, then swallow. If needing more support, increase to 1 full lozenge. Take as needed. Do not take within 5 hours of bedtime as it may interfere with sleep. Use as directed by your healthcare professional.
Warning
Keep closed in a cool, dry place out of reach of children. Do not use if inner tamper seal is damaged.
Product Info
- Brand
- Seeking Health
- UPC
- 810007520490
- Package Qty
- 60 count
- Dimensions
- 3.3 x 1.8 x 1.8 in
- Shipping Weight
- 0.08 lb
- First Available
- 06/2023
